FM Trademark
Trademark Overview
On Friday, March 28, 2025, a trademark application was filed for FM with the United States Patent and Trademark Office. The USPTO has given the FM trademark a serial number of 99108590. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, July 8, 2026. This trademark is owned by Frontier Medicines Corporation. The FM trademark is filed in the Pharmaceutical Products category with the following description:
Small molecule pharmaceuticals for the treatment of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, infectious diseases, pain, peripheral neuropathy, inflammatory disease, autoimmune disease, ulcerative colitis, atopic dermatitis, plaque psoriasis, chronic obstructive pulmonary disease, Crohn's disease, eosinophilic esophagitis, systemic lupus erythematosus, multiple sclerosis, age-related diseases in the nature of Huntington's Disease, rare diseases in the nature of Lysosomal storage disorders, Peroxisomal disorders, Transthyretin Amyloid Cardiopathy (ATTR-CM), Alpha-1 Antitrypsin Deficiency (AATD), ENPP1 deficiency and vitamin D-dependent rickets diseases (VDDR), and pediatric diseases in the nature of Medulloblastoma, Pediatric Acute Lympho...
General Information
| Serial Number | 99108590 |
| Word Mark | FM |
| Filing Date | Friday, March 28, 2025 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Wednesday, July 8, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 9, 2025 |
Trademark Statements
| Goods and Services | Small molecule pharmaceuticals for the treatment of heart disease, blood pressure, Alzheimer's disease, arthritis, diabetes, obesity, mitochondrial disease, autoimmune diseases, hypertension, inflammatory bowel disease, amyotrophic lateral sclerosis, neurological diseases, allergies and asthma, hepatic disease, pulmonary disease, renal disease, infectious diseases, pain, peripheral neuropathy, inflammatory disease, autoimmune disease, ulcerative colitis, atopic dermatitis, plaque psoriasis, chronic obstructive pulmonary disease, Crohn's disease, eosinophilic esophagitis, systemic lupus erythematosus, multiple sclerosis, age-related diseases in the nature of Huntington's Disease, rare diseases in the nature of Lysosomal storage disorders, Peroxisomal disorders, Transthyretin Amyloid Cardiopathy (ATTR-CM), Alpha-1 Antitrypsin Deficiency (AATD), ENPP1 deficiency and vitamin D-dependent rickets diseases (VDDR), and pediatric diseases in the nature of Medulloblastoma, Pediatric Acute Lymphoblastic Leukemia (ALL) in humans |
| Description of Mark | The mark consists of stylized letters "F" and "M". |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 28, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Frontier Medicines Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080
US |
| Party Name | Frontier Medicines Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080
US |
Trademark Events
| Event Date | Event Description |
| Friday, March 28, 2025 | NEW APPLICATION ENTERED |
| Friday, March 28, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, August 12, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 12, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, August 26, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, September 3, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 3, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 3, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 12, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, November 12, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 12, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 13, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 3, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 9, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 9, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 3, 2026 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 7, 2026 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 7, 2026 | SOU EXTENSION 1 FILED |
| Wednesday, July 8, 2026 | SOU EXTENSION 1 GRANTED |
